Dearth of ICD Codes for Complications of Immune Checkpoint Inhibitors Impedes Clinical Care and Research

Immune checkpoint inhibitors (ICIs) are a rapidly expanding class of targeted therapies effective in the treatment of various cancers. However, while efficacious, ICIs have been associated with treatment complications, namely immune-related adverse events (irAEs). IrAEs of the endocrine system are a...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheung, Yee-Ming M, Hamnvik, Ole-Petter R, Shariff, Afreen, Gallagher, Emily J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933895/
https://www.ncbi.nlm.nih.gov/pubmed/36819460
http://dx.doi.org/10.1210/jendso/bvad019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933895/
https://www.ncbi.nlm.nih.gov/pubmed/36819460
http://dx.doi.org/10.1210/jendso/bvad019

Ejemplares similares